Search icon

EYENOVIA, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: EYENOVIA, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 12 Jan 2018 (8 years ago)
Entity Number: 5266015
ZIP code: 10017
County: New York
Place of Formation: Delaware
Address: 295 MADISON AVENUE, SUITE 2400, NEW YORK, NY, United States, 10017

DOS Process Agent

Name Role Address
EYENOVIA, INC. DOS Process Agent 295 MADISON AVENUE, SUITE 2400, NEW YORK, NY, United States, 10017

Chief Executive Officer

Name Role Address
MICHAEL ROWE Chief Executive Officer 295 MADISON AVENUE, SUITE 2400, NEW YORK, NY, United States, 10017

U.S. Small Business Administration Profile

Phone Number:
E-mail Address:
Fax Number:
833-393-6684
Contact Person:
ERIC TROSKO
User ID:
P3335427

Form 5500 Series

Employer Identification Number (EIN):
471178401
Plan Year:
2024
Number Of Participants:
64
Sponsors Telephone Number:
Plan Year:
2023
Number Of Participants:
54
Sponsors Telephone Number:
Plan Year:
2022
Number Of Participants:
47
Sponsors Telephone Number:
Plan Year:
2021
Number Of Participants:
33
Sponsors Telephone Number:
Plan Year:
2020
Number Of Participants:
25
Sponsors Telephone Number:

History

Start date End date Type Value
2024-02-28 2024-02-28 Address 295 MADISON AVENUE, SUITE 2400, NEW YORK, NY, 10017, USA (Type of address: Chief Executive Officer)
2020-02-04 2024-02-28 Address 295 MADISON AVENUE, SUITE 2400, NEW YORK, NY, 10017, USA (Type of address: Chief Executive Officer)
2020-02-04 2024-02-28 Address 295 MADISON AVENUE, SUITE 2400, NEW YORK, NY, 10017, USA (Type of address: Service of Process)
2018-01-12 2020-02-04 Address 501 FIFTH AVENUE,, SUITE 1404, NEW YORK, NY, 10017, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
240228003076 2024-02-28 BIENNIAL STATEMENT 2024-02-28
220304000174 2022-03-04 BIENNIAL STATEMENT 2022-01-01
200204061839 2020-02-04 BIENNIAL STATEMENT 2020-01-01
180112000301 2018-01-12 APPLICATION OF AUTHORITY 2018-01-12

USAspending Awards / Financial Assistance

Date:
2020-05-03
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
463353.00
Total Face Value Of Loan:
463353.00
Date:
2020-04-29
Awarding Agency Name:
Small Business Administration
Transaction Description:
ECONOMIC INJURY DISASTER GRANT
Obligated Amount:
10000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
97808709
Mark:
MYDCOMBI
Status:
NOTICE OF ALLOWANCE - ISSUED
Mark Type:
TRADEMARK
Application Filing Date:
2023-02-23
Mark Drawing Type:
Illustration: Drawing or design which also includes word(s)/letter(s)/number(s)
Mark Literal Elements:
MYDCOMBI

Goods And Services

For:
Ocular pharmaceuticals; Pharmaceutical preparations, namely, mydriatics and anticholinergics; Preparations for pharmaceutical or medical purposes, namely, for eye pupil dilation; Drug and drug delivery system, namely, ophthalmic spray dispenser sold filled with mydriatics; pupil dilating preparation...
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
97086061
Mark:
SIGHT. UNSEEN.
Status:
FOURTH EXTENSION - GRANTED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2021-10-21
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
SIGHT. UNSEEN.

Goods And Services

For:
Pharmaceutical preparations for the treatment, prevention, and management of diseases, disorders, and conditions of the eye; pharmaceutical products for use in ophthalmology; therapeutics agents for presbyopia, mydriasis, and myopia; medicated eye drops and eye sprays; drug and drug delivery system,...
International Classes:
005 - Primary Class
Class Status:
Active
For:
ophthalmic drug delivery system, namely ophthalmic spray dispenser sold empty
International Classes:
010 - Primary Class
Class Status:
Active
For:
Research and development services in the fields of ophthalmology, ocular pharmaceuticals, and ophthalmic drug delivery technologies; providing medical scientific research information in the fields of ophthalmology, ocular pharmaceuticals, and ophthalmic drug delivery technologies
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
97011370
Mark:
EYENOVIA
Status:
REGISTERED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2021-09-03
Mark Drawing Type:
Illustration: Drawing or design which also includes word(s)/letter(s)/number(s)
Mark Literal Elements:
EYENOVIA

Goods And Services

For:
Pharmaceutical preparations for the treatment, prevention, and management of diseases, disorders, and conditions of the eye; pharmaceutical products for use in ophthalmology; therapeutics agents for presbyopia, mydriasis, and myopia; medicated eye drops and eye sprays; drug and drug delivery system,...
International Classes:
005 - Primary Class
Class Status:
Active
For:
ophthalmic drug delivery system, namely ophthalmic spray dispenser sold empty
International Classes:
010 - Primary Class
Class Status:
Active
For:
Research and development services in the fields of ophthalmology, ocular pharmaceuticals, and ophthalmic drug delivery technologies; providing medical scientific research information in the fields of ophthalmology, ocular pharmaceuticals, and ophthalmic drug delivery technologies
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
97011367
Mark:
EYENOVIA
Status:
REGISTERED
Mark Type:
TRADEMARK, SERVICE MARK
Application Filing Date:
2021-09-03
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
EYENOVIA

Goods And Services

For:
Pharmaceutical preparations for the treatment, prevention, and management of diseases, disorders, and conditions of the eye; pharmaceutical products for use in ophthalmology; therapeutics agents for presbyopia, mydriasis, and myopia; medicated eye drops and eye sprays; drug and drug delivery system,...
International Classes:
005 - Primary Class
Class Status:
Active
For:
Research and development services in the fields of ophthalmology, ocular pharmaceuticals, and ophthalmic drug delivery technologies; providing medical scientific research information in the fields of ophthalmology, ocular pharmaceuticals, and ophthalmic drug delivery technologies
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
90759191
Mark:
APERSURE
Status:
REGISTERED
Mark Type:
TRADEMARK
Application Filing Date:
2021-06-07
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
APERSURE

Goods And Services

For:
Pharmaceutical preparations for treatment of ocular diseases and conditions; ophthalmic pharmaceuticals; therapeutic preparations for treatment of presbyopia; eye drops; therapeutic eye spray for treatment of ocular diseases and conditions
International Classes:
005 - Primary Class
Class Status:
Active

Paycheck Protection Program

Jobs Reported:
29
Initial Approval Amount:
$463,353
Date Approved:
2020-05-01
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$463,353
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$469,090.96
Servicing Lender:
Wells Fargo Bank, National Association
Use of Proceeds:
Payroll: $463,353

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 24 Mar 2025

Sources: New York Secretary of State